Clinical Trials Logo
  1. Home
  2. Pain, Intractable
  3. NCT02687347

Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain — UDOME  

Pain, Intractable Clinical Trial

Official title:
A Double Blind Randomized Clinical Trial to Investigate the Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic Therapy in Cancer Patients With Pain

Clinical Trial Summary

The research hypothesis of this study is: In patients with moderate to severe cancer related pain, the addition of low dose methadone to an existing opioid significantly reduces pain severity compared to low doses morphine.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02687347
Study type Interventional
Source McGill University Health Center
Contact
Status Recruiting
Phase Phase 3
Start date February 2016
Completion date December 2018
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03887494 - Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY) N/A
Recruiting NCT05761392 - APP-based Precise Management System of Chronic Intractable Pain N/A
Suspended NCT05067257 - Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer Phase 2
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Withdrawn NCT01951911 - Effectiveness of Ketamine in Malignant Neuropathic Pain Relief Phase 3
Completed NCT04701008 - Efficacy of Ketamine in Post Anesthesia Recovery Room
Completed NCT03350256 - BurstDR™ micrOdosing stimuLation in De-novo Patients N/A
Completed NCT04602286 - How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample) N/A
Completed NCT04625504 - Investigating Biological Targets, Markers, and Intervention for Chronic Pain N/A
Recruiting NCT05398003 - Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M) N/A
Completed NCT02886286 - Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain Phase 4
Completed NCT00216684 - Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics Phase 3
Recruiting NCT05775510 - Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain
Active, not recruiting NCT04727216 - Intermittent vs. Continuous Dorsal Root Ganglion Stimulation N/A
Completed NCT02091076 - Efficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing Phase 1/Phase 2
Completed NCT01166906 - Pain Blocking During Drug Administration or Blood Collection With Needles
Recruiting NCT04876469 - Radiocontrast Media in the Pulsed Radiofrequency Treatment N/A
Completed NCT05108103 - Determination of Longus Colli Muscle Thickness by Ultrasonography
Completed NCT04727749 - Pawsitive Impacts of Therapy Dog Visits N/A
Completed NCT04096391 - Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population N/A